Tag Archives: big pharma

Sex-Linked Links

Debbie says:

Last time I set out to do a links round-up, I wound up with a themed post on penises. This time, I’m finding a set of themed links on human sexuality. One day, we’ll have a real wide-ranging links round-up … but not today.

299px-Sperm-egg

Diane Kelly at Throb shares an interesting insight into why more babies are boys than girls … and why what we’ve always believed about that is wrong.

For nearly two centuries, experts have assumed that the skew came from a higher rate of male conceptions. In an article at Nautilus, David Steinsaltz, J. W. Stubblefield, and J. E. Zuckerman explain that an early, 19th-century guess that more males were conceived to compensate for greater losses in utero–the so-called “fragile male” hypothesis–snowballed into a rarely-questioned “truth. …

In fact, new methods of looking at the sex ratio during development have shown that … X and Y sperm are equally likely to fertilize any given egg. The skew comes instead from differences in survival rates during embryonic development. There’s a complex shift in miscarriage ratios over time, from more males to more females at different moments in gestation. In the end, more female embryos are lost to miscarriage, skewing the birth ratio slightly to males.

I will forbear from making jokes about the “fragile male” hypothesis. Really I will.

***

In other news, the FDA has approved Addyi, a libido-enhancing drug for women. This sounds like good news, but Sarah Boseley at The Guardian is viewing it with alarm, and I think she makes sense.

[Cynthia] Graham, [professor in sexual and reproductive health at the University of Southampton] and other critics believe the FDA was pressured and half-shamed into approving Addyi (generic name flibanserin) by a campaign headed by a vocal group called Even the Score, which pitched the absence of drugs to help women with low libido as a gender inequality issue. It describes itself as a campaign for women’s sexual health equality which was “created to serve as a voice for American women who believe that it’s time to level the playing field when it comes to the treatment of women’s sexual dysfunction”. On the front page of its website now runs a banner saying “Thank you, FDA”. Sprout Pharmaceuticals, which owns Addyi, is one of the funders, as is Trimel, another company in the same field.

Nothing makes me more nervous than “grassroots” political groups which turn out to be funded by corporations with a financial interest in their activism. And learning that Addyi is “only moderately effective, should not be taken with alcohol, and has potentially serious side-effects” doesn’t calm my nerves.  I also appreciate the comments by Dr. Petra Boynton, an extremely smart and sensible analyst of sexual issues, who said:

“People have a perception that everybody else is having fantastic sex all the time with exotic positions.” There is, Boynton said, “anxiety brought about by misinformation about sex”, which is perpetuated by the media and especially men’s and women’s magazines. “The cultural wallpaper is telling you that to keep someone and be desirable and not left alone, which is a huge fear, you must be having and providing frequent sex.”

***

In a related vein, Mona Chalabi at 538 is talking about “the gender orgasm gap” from her point of view as a data analyst:

In 2009, the National Survey of Sexual Health and Behavior (NSSHB) asked 1,931 U.S. adults ages 18 to 59 about their most recent sexual experience. The topline findings show that men are more likely to orgasm than women — 91 percent of men said they climaxed during their last sexual encounter, compared with 64 percent of women.

But there seems to be a perception gap, too — at least among men. Eighty-five percent of men said their partners in that recent sexual encounter had reached climax, far higher than the percentage of women who said they orgasmed. That can’t simply be explained away by saying that the men were referring to different sexual partners. Most of these sexual encounters were heterosexual — 92 percent of men and 98 percent of women said their last sexual encounter was with someone of the opposite sex. So it seems like some of those men were wrong when they said their partners had orgasmed — either their egos are causing them to overestimate, or some of those women are faking it.

Nothing surprising here (and it’s six-year-old data); nonetheless, 538 is always refreshing because of its focus on data. Chalabi has a lot more to say about which sexual acts, done with whom (including alone), etc.  And who can resist a chart about what acts lead to orgasm entitled “How Come?”

***

Finally, Liz Prato at Hippocampus has a rich, nuanced article about female masseuses, male clients, and erections.

Massage school was the first to teach me that there were two types of erections: hostile and benign. My instructors taught me how to deal with each erectile happenstance, ranging from saying nothing at all, to having a clinical discussion with the engorged client about what’s appropriate behavior during a massage. I was confident that, by the time I graduated from massage school, I would have no problems dealing with erections, hostile or otherwise. After all, I’d seen a few in my private life without eliciting trauma, and (thought) I had a clear concept of professional boundaries. This would be no big deal.

My first encounter with a hostile erection popped up a lot sooner than I expected. … My school was a blond brick office building with bleached linoleum floors and industrial-grade carpet (in other words, not a bordello), and my student uniform was khaki pants and a green polo shirt (not a mini skirt and knee-high fuck me boots). My client was in his mid-twenties, with dark hair and a cheesy mustache. The massage began with him lying on his stomach, so if there was an erection, I didn’t see it. Sure, he moaned and groaned a little, but, Hey, some people are expressive, I reasoned. But when he turned over, there it was, pitching a tent under the thin white sheet.

Okay, ignore it, was my tactic. I figured bringing attention to the erection was always the wrong way to go, and just massaged his shoulders. That’s when his moaning turning into loud groaning. “Oh, God, oh, yes! It feels so good!”

Prato goes on to discuss the relationship between massage and sexuality, between touch and sexuality, and the complexities this entails. She looks at the issues with directness and compassion:

I used to have a forty-something client named Tom who saw me weekly. He was referred by a psychotherapist who treats sex addicts. It’s not as creepy as it sounds. I’ve worked with several recovering sex addicts, and they’re no more interested in a Happy Ending than anyone else who lies on my table. These folks have a pretty good idea of where to go for sex and don’t want to waste my time and theirs if that’s what they’re looking for. What they are looking for is touch that’s not a futile attempt to mask their emotional pain. See, for them, sex isn’t about pleasure, and it sure as hell isn’t about intimacy. It’s usually about trying to cover up some horrible wound inside of them, but that’s like trying to douse a flame with kerosene. All it does is create a firestorm of emptiness and shame. When they come to me they want touch that isn’t sexual. They want intimacy with boundaries. They want – and they get – no self-hatred.

When I lay my hands against their skin, it might very well be the first time that touch hasn’t been manipulative or degrading. So they come back. Each time I touch them, they relax a bit more. They feel a little more pleasure. They get a little less scared. It reminds me of how we all walk around carrying fear and self-doubt and weeping wounds, and we’re just doing the best we can to dance around all that pain. I wish I didn’t need to be reminded of that, but I’m so glad I am.

Read the rest; Prato is a fascinating writer.

Thanks to oursin for the Addyi link; the others are from my regular reading

Birth Control: Back in the News

Laurie and Debbie say:

We were very impressed by this article by Valerie Tarico at truthout.org . Tarico couches excellent contemporary birth-control information in the context of Rick Santorum’s recent attack on birth control (“It’s not okay. It’s a license to do things in a sexual realm that is counter to how things are supposed to be.”).

Good news: Even if you feel hazy or muddled right now, you likely have access to technologies your parents could only have dreamed of. Bad news: The confusion is no accident.

Although the headline implies that she is simply writing about birth control misinformation coming from the right wing, the article is much more nuanced than that. She covers five things the right wing doesn’t want you to know about birth control, five that big pharma doesn’t want you to know, and five that the medical gatekeepers don’t want you to know. One thing all of these groups have in common is that they don’t want women to be able to control our bodies. Here’s one from each group:

Right wing: IUDs work by preventing eggs and sperm from hooking up. Opponents of abortion and contraception would have us believe that virtually all modern contraceptives are abortifacients. They especially have targeted the most effective contraceptives available, IUDs, with this accusation. In reality copper IUDs like the Paragard work primarily by inhibiting sperm motility, thus preventing fertilization. Hormonal IUDs like the Mirena work primarily by thickening a plug at the opening to the cervix —another means of preventing fertilization–and secondarily by decreasing ovulation. …

Pharma: The best contraception is also the cheapest. The most effective contraceptives on the market have the potential to kill some of Pharma’s big profit streams. The Paragard copper IUD, which is top tier from an efficacy standpoint (over 99%) offers the cheapest month over month contraception. The problem for Pharma: you put it in once and then don’t spend any money on contraception for the next 10 years. The Mirena hormonal IUD (99.8% effective once established), is more expensive, but has the side benefit of reducing menstrual bleeding and cramps over time by an average of 90%. Family planning practitioners who promote LARCs joke about putting themselves out of business. In contrast, Tarico says that one in twelve women on the pill gets pregnant each year, a higher number than we would have guessed.

Medical gatekeepers: The FDA lags behind. European women have an array of contraceptive options that either never make it to market in the U.S. or are delayed by anywhere from 5-20 years. American regulators are influenced by a litigious environment and by religious fundamentalists, which skew the equation toward inaction. For example, Nexplanon, the latest iteration of the implant, only just became available in the U.S. Similarly, the Mirena IUD has a long track record with women of all ages in Europe but is not yet approved for childless women here. By the time it was officially sanctioned in the US to regulate heavy menstrual bleeding (2009), it was already in use for contraception or bleeding by 15 million women worldwide. A frameless IUD optimized for small women is approved in the E.U., but hasn’t yet reached the U.S. market. If you want to know where contraception is headed, take a look at what Europeans are doing.

Many of the other fifteen points are just as rarely discussed.

So it got us to wondering why birth control has gotten so little attention and discussion over the past couple of decades.

One answer is obvious: the three groups that Tarico singles out are happiest if there isn’t a lot of conversation.

Another is that abortion is getting so much attention and is under such intense attack. This means that the heroes fighting to keep abortion safe and legal are too busy to look at birth control, and that the anti-abortion warriors are really busy with their main campaign. The war on abortion has pushed some of the truly fine birth control resources under the radar: Planned Parenthood (link below) not only has to spend energy fighting it enemies, it has to do what it can to stay out of the public eye, because every time it shows up in the news, the attacks get more fervent. Tarico’s other recommended resource, Bedsider (a new site launched by the National Campaign to Prevent Teen and Unplanned Pregnancy), is one neither of us had even heard of, and it looks excellent.

But why aren’t feminists talking much about contraception? Our guess is that it’s generally thought of as a “solved problem.” In most places in the United States, women who want contraception can get something. And feminists, with so many hot-button issues to concentrate on, may have been too busy to notice that that something is served with large doses of preconception, misinformation, and monetary gain. So wrong-headed Rick Santorum is, for the worst possible reasons, calling attention to something we need to look at more closely.

So, to close with more of Tarico’s words,

You really can manage your contraception. A decision about contraception can shape the rest of your life—your happiness, your ability to contribute to the world around you, the wellbeing of your children. Only you can weigh the risks and benefits of any given contraception against each other in the context of your lifestyle and life goals. To make the best decision possible, you need accurate information, and that means knowing what questions to ask, who to ask, and what factors may be biasing answers. An hour on the internet can fill your mind with rubbish about almost any medical technology. Alternately, an hour spent on sites that are rigorously fact based could mean you have more up-to-date information than your peers or even your doctor. (Bedsider.org and Planned Parenthood are among the best.) Tarico doesn’t mention Scarleteen’s excellent birth control bingo interactive site, so we will.

Thanks to F.S.J. Ledgister, who linked to this on Google+